Type 2 diabetes. Type 2 diabetes
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Type 2 diabetic patients of Loghman Hakim Hospital A1C more than 6% Lack of Orthopedic diseases Age limit (45 to 60 years) male and female lack of neuromuscular disease lack of Nephropathy lack of Hypertension lack of Myocardial infarction lack of Bypass surgery
Exclusion criteria
Exclusion criteria: Orthopedic diseases neuromuscular disease Nephropathy Hypertension Myocardial infarction Bypass surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Liver enzyme plasma levels. Timepoint: 24 hours before the intervention period and 48 hours after the intervention period. Method of measurement: ELISA. | — |
Secondary
| Measure | Time frame |
|---|---|
| Fatty liver index. Timepoint: 24 hours before the intervention period and 48 hours after the intervention period. Method of measurement: Fatty liver index (FLI) is a non-invasive method for assessing hepatic steatosis which calculated by following formula: FLI= (e 0.953 × loge (triglycerides) + 0.139 × BMI + 0.718 × loge (GGT) + 0.053 × waist circumference – 15.745)/ (1 + e 0.953 × loge (triglycerides) + 0.139 × BMI + 0.718 × loge (GGT) + 0.053 × waist circumference – 15.745) × 100. The FLI was calculated in each subjects.;Lipid profile. Timepoint: 24 hours before the intervention period and 48 hours after the intervention period. Method of measurement: ELISA.;HbA1c. Timepoint: 24 hours before the intervention period and 48 hours after the intervention period. Method of measurement: ELISA.;Renal function, measurement of urea and creatinine. Timepoint: 24 hours before the intervention period and 48 hours after the intervention period. Method of measurement: Quantified by photometry. | — |
Countries
Iran (Islamic Republic of)
Contacts
Shahid Beheshti University of Medical Sciences